The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses

Veterinary Immunology and Immunopathology

Volumn 108, Issue 3-4, 2005, Pages 345-355

  Crouch, C F ^a   Daly, J ^b   Henley, William ^b   Hannant, D ^b   Wilkins, J ^a   Francis, M J ^a  

^a Schering Plough Animal Health   (United Kingdom)

^b ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

Equine influenza; Horse; ISCOM vaccine; Protective immunity

Indexed keywords

IMMUNOGLOBULIN A; INFLUENZA VACCINE; ISCOM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HORSE; IMMUNITY; IMMUNIZATION; INFLUENZA; MUCOSA; NONHUMAN; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; HORSE DISEASES; HORSES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H3N8 SUBTYPE; INFLUENZA VACCINES; ISCOMS; MALE; ORTHOMYXOVIRIDAE INFECTIONS; VIRUS SHEDDING;

ANIMALIA; EQUIDAE; EQUUS CABALLUS; INFLUENZA VIRUS;

EID: 26944436283     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2005.06.009     Document Type: Article

References (62)

1. A.J. Almeida, and H.O. Alpar Nasal delivery of vaccines J. Drug Target. 3 1996 455 467
2. B.P. Arulanandam, R.H. Raeder, J.G. Nedrud, D.J. Bucher, J. Le, and D.W. Metzger IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection J. Immunol. 166 2001 226 231
3. I. Babai, S. Samira, Y. Barenholz, Z. Zakay-Rones, and E. Kedar A novel influenza subunit vaccine composed of liposome encapsulated haemagglutinin/ neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice Vaccine 17 1999 1223 1238
4. I.G. Barr, A. Sjolander, and J.C. Cox ISCOMs and other saponin based adjuvants Adv. Drug. Deliv. Rev. 32 1998 247 271
5. R.B. Belshe, W.C. Gruber, P.M. Mendelman, H.B. Mehta, K. Mahmood, and K. Reisinger Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine J. Infect. Dis. 181 2000 1133 1137
6. E.T. Ben Ahmeida, G. Gregoriadis, C.W. Potter, and R. Jennings Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice Vaccine 11 1993 1302 1309
7. T.G. Boyce, W.C. Gruber, S.D. Coleman-Dockery, E.C. Sannella, G.W. Reed, and M. Wolff Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children Vaccine 18 1999 82 88
8. H. Carol, A. Nieto, M. Villacres-Ericsson, and B. Morein Intranasal immunization of mice with Echinococcus granulosus surface antigens. Iscoms evoke astrong immune response biased towards gludicic epitopes Parasite Immunol. 19 1997 197 205
9. H. Carol, and A. Nieto A mucosal IgA response, but no systemic antibody response is evoked by intranasal immunisation of dogs with Echinococcus granulosus surface antigens iscoms Vet. Immunol. Immunopathol. 65 1998 29 41
10. M.L. Clements, R.F. Betts, E.L. Tierney, and B.R. Murphy Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus J. Clin. Microbiol. 24 1986 157 160
11. J. Cox, and A. Coulter Adjuvants - a classification and review of their modes of actions Vaccine 15 1997 248 256
12. A.W. Cripps, J.M. Kyd, and A.R. Foxwell Vaccines and mucosal immunisation Vaccine 19 2001 2513 2515
13. C.F. Crouch, J. Daly, D. Hannant, J. Wilkins, and M.J. Francis Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus Vaccine 23 2004 418 425
14. D.L. Foss, and M.P. Murtaugh Mechanisms of vaccine adjuvanticity at mucosal surfaces Anim. Health Res. Rev. 1 2000 3 24
15. S. Grund, H.J. Selbitz, P. Kutzer, S. Springer, and J. Eichberg Vaccination of pigeons against Salmonella infections Berl. Munch. Tierarztl. Wochenschr. 110 1997 171 175
16. D. Hannant, R. Easeman, and J.A. Mumford Equine mucosal immune system: intranasal vaccination with inactivated equine influenza virus protects from infection U. Wernery J.F. Wade J.A. Mumford O.-R. Kaaden Proceedings of the 8th International Conference on Equine Infectious Diseases Dubai 1999 R and W Publications (Newmarket) Ltd. 50 56
17. J. Holmgren, C. Czerkinsky, N. Lycke, and A.-M. Svennerholm Mucosal immunity: implications for vaccine development Immunobiology 184 1992 157 179
18. S.C. Hsu, E.B. Schadeck, A. Delmas, M. Shaw, and M.W. Steward Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization Vaccine 14 1996 1159 1166
19. K.F. Hu, M. Elvander, M. Merza, L. Akerblom, A. Brandenburg, and B. Morein The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses Clin. Exp. Immunol. 113 1998 235 243
20. Insightful S-LUS 6 Guide to Statistics for Windows 2001 Insightful Corporation Seattle
21. P.R. Johnson, S. Feldman, J.M. Thompson, J.D. Mahoney, and P.F. Wright Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine and inactivated vaccine J. Infect. Dis. 154 1986 121 127
22. P.D. Jones, R. Tha Hla, B. Morein, K. Lovgren, and G.L. Ada Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes Scand. J. Immunol. 27 1988 645 652
23. T.G. Lauterslager, and L.A. Hilgers A multiple dose immunisation protocol suitable for edible vaccines Internet J. Infect. Dis. 2 2002
24. T.G.M. Lauterslager, W. Stok, and L.A.T. Hilgers Improvement of the systemic prime/oral boost strategy for systemic and local responses Vaccine 21 2003 1391 1399
25. G.T. Layton, and A.M. Smithyman The effects of oral and combined parenteral/oral immunisation against as experimental E. coli urinary tract infection in mice Clin. Exp. Immunol. 54 1983 305 312
26. M. Leenars, M.A. Koedam, C.F. Hendricksen, and E. Claassen Immune responses and side effects of five different oil-based adjuvants in mice Vet. Immunol. Immunopathol. 61 1998 291 304
27. F.Y. Liew, S.M. Russell, G.A. Appleyard, C.M. Brand, and J. Beale Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity Eur. J. Immunol. 14 1984 350 356
28. K. Lovgren The serum antibody responses distributed in subclasses and isotypes following intranasal and subcutaneous immunization with influenza virus iscoms Scand. J. Immunol. 2 1988 241 245
29. K. Lovgren, H. Kaberg, and B. Morein An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration Clin. Exp. Immunol. 82 1990 435 439
30. D.P. Lunn, M.A. Holmes, and D.F. Antczak Summary report of the Second Equine Leucocyte Antigen Workshop Vet. Immunol. Immunopathol. 54 1996 159 161
31. M.B. Mazanec, C.S. Kaetzel, M.E. Lamm, D. Fletcher, and J.G. Nedrud Intracellular neutralization of virus by immunoglobulin A antibodies Proceedings of the National Academy of Science, vol. 89 USA 1992 pp. 6901-6905
32. M.R. McDermott, and J. Bienenstock Evidence for a common mucosal system. I. Migration of B immunoblasts into intestinal, respiratory and genital tissues J. Immunol. 122 1979 1892 1898
33. J.R. McGhee, M.T. Mestecky, J.H. Dertzbaugh, J.H. Eldridge, M. Hirasawa, and H. Kiyono The mucosal immune system: from fundamental concepts to vaccine development Vaccine 10 1992 75 88
34. Z. Moldoveanu, L. Love-Homan, W_Q. Huang, and A.M. Krieg CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus Vaccine 16 1998 1216 1224
35. B. Morein, B. Sundquist, S. Höglund, K. Dalsgaard, and A. Osterhaus Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses Nature 308 1984 457 460
36. B. Morein, K. Lövgren, S. Höglund, and B. Sundquist The ISCOM: an immunostimulating complex Immunol. Today 8 1987 333 338
37. P.S. Morley, H.H.G. Townsend, J.R. Bogdan, and D.M. Haines Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses J. Am. Vet. Med. Assoc. 215 1999 61 66
38. J.A. Mumford, J.M. Wood, C. Folkers, and G.C. Schild Protection against experimental infection with influenza virus A/equine /Miami/63(H3N8) provided by inactivated whole virus vaccines containing homologous virus Epidemiol. Infect. 100 1988 501 510
39. J.A. Mumford, D. Hannant, and D.M. Jessett Experimental infection of ponies with equine influenza (H3N8) viruses by intranasal inoculation or exposure to aerosols Equine Vet. J. 22 1990 93 98
40. J.A. Mumford, and J. Wood Establishing an acceptability threshold for equine influenza vaccines Dev. Biol. Stand. 79 1992 137 146
41. J.A. Mumford, D.M. Jessett, E.A. Rollinson, D. Hannant, and M.E. Draper Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines Vet. Rec. 134 1994 158 162
42. J.A. Mumford, D. Jessett, U. Dunleavy, J. Wood, D. Hannant, B. Sundquist, and R.F. Cook Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines Vaccine 12 1994 857 863
43. B.R. Murphy, and M.L. Clements The systemic and mucosal immune response of humans to influenza A virus Curr. Top. Microbiol. Immunol. 146 1989 107 116
44. K.M. Nelson, B.R. Schram, M.W. McGrergor, A.S. Sheoran, C.W. Olsen, and D.P. Lunn Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination Vaccine 16 1998 1306 1313
45. J.R. Newton, and J.A. Mumford Equine influenza in vaccinated horses Vet. Rec. 137 1995 495 496
46. H.H. Nguyen, F.W. van Ginkel, H.L. Vu, J.R. McGhee, and J. Mestecky Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes J. Infect. Dis. 183 2001 368 376
47. D.T. O'Hagan D.T. O'Hagan Novel Delivery Systems for Oral Vaccines vol. 1 1994 CRC Press Boca Raton 1 26
48. P.L. Ogra, H. Faden, and R.C. Welliver Vaccination strategies for mucosal immune responses Clin. Microbiol. Rev. 14 2001 430 445
49. N.F. Pierce, R.B. Sack, and B.K. Sircar Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs J. Infect. Dis. 135 1977 888 896
50. R. Rappuoli, M. Pizza, G. Douce, and G. Dougan Structure and mucosal adjuvanticity of cholera and E. coli heat-labile enterotoxins Immunol. Today 20 1999 493 500
51. K.B. Renegar, and P.A. Small Jr. Passive transfer of local immunity to influenza virus infection by IgA antibody J. Immunol. 146 1991 1972 1978
52. K.B. Renegar, and P.A. Small Jr. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity J. Virol. 65 1991 2146 2148
53. S. Sjolander, D. Drane, R. Davis, L. Beezum, M. Pearse, and J. Cox Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytptoxic T-lymphocyte responses Vaccine 19 2001 4072 4080
54. A. Takada, S. Matsushita, A. Ninomiya, Y. Kawaoka, and H. Kida Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice Vaccine 21 2003 3212 3218
55. S. Tamura, H. Funato, Y. Hirabayashi, K. Kikuta, Y. Suzuki, T. Nagamine, C. Aizawa, M. Nakagawa, and T. Kurata Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza Vaccine 8 1990 479 485
56. S. Tamura, H. Funato, Y. Hirabayashi, Y. Suzuki, T. Nagamine, C. Aizawa, and T. Kurata Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules Eur. J. Immunol. 21 1991 1334 1337
57. H.G.G. Townsend, S.J. Penner, T.C. Watts, A. Cook, J. Bogdan, D.M. Haines, S. Griffin, T. Chambers, R.E. Holland, P. Whitaker-Dowling, J.S. Younger, and R.W. Sebring Efficacy of a cold adapted, intranasal, equine influenza vaccine: challenge trials Equine Vet. J. 33 2001 637 643
58. M. Ugozzoli, D.T. O'Hagan, and G.S. Ott Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses Immunology 93 1998 563 571
59. P.J. van der Heijden, A.T. Bianchi, B.A. Bokhout, M. Dol, J.W. Scholten, and W. Stok Quantification of antigen-specific antibody-secreting cells in the small intestine and other lymphoid organs of mice after oral booster immunisation Immunology 66 1989 404 409
60. C. van Maanen, G.J. van Essen, J. Minke, J.M. Daly, and P.J. Yates Diagnostic methods applied to analysis of an outbreak of equine influenza in a riding school in which vaccine failure occurred Vet. Microbiol. 93 2003 291 306
61. Wood, J.L.N., 1991. Equine influenza: history and epidemiology and a description of a recent outbreak. M.Sc. Thesis, University of London.
62. J.M. Wood, J. Mumford, C. Folkers, A.M. Scott, and G.C. Schild Studies with inactivated equine influenza vaccine. I. Serological responses of ponies to graded doses of vaccine J. Hyg. (Camb.) 90 1983 371 384